Literature DB >> 2869316

Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases.

H D Ochs, S H Fischer, M L Lee, E S Delson, H S Kingdon, R J Wedgwood.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 2869316     DOI： 10.1016/s0140-6736(86)92826-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Self-infusion with immunoglobulin at home.

Authors:  H Chapel; V Brennan
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

3.  Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy.

Authors:  U Nicolay; S Haag; F Eichmann; S Herget; D Spruck; A Gardulf
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

4.  Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home.

Authors:  Uwe Nicolay; Peter Kiessling; Melvin Berger; Sudhir Gupta; Leman Yel; Chaim M Roifman; Ann Gardulf; Florian Eichmann; Stefan Haag; Cordula Massion; Hans D Ochs
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

5.  The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.

Authors:  H M Chapel; G P Spickett; D Ericson; W Engl; M M Eibl; J Bjorkander
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

6.  The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.

Authors:  A Gardulf; H Björvell; R Gustafson; L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

Review 7.  Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis.

Authors:  Hassan Abolhassani; Mohammad Salehi Sadaghiani; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2012-06-23       Impact factor: 8.317

8.  Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease.

Authors:  Jennifer Heimall; Junliang Chen; Joseph A Church; Rhonda Griffin; Isaac Melamed; Gary I Kleiner
Journal:  J Clin Immunol       Date:  2016-06-25       Impact factor: 8.317

Review 9.  Intravenous immune globulins. A review of their uses in selected immunodeficiency and autoimmune diseases.

Authors:  B Pirofsky; D M Kinzey
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

10.  Immunoglobulin replacement therapy by self-infusion at home.

Authors:  H Chapel; V Brennan; E Delson
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.